Stay updated on Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.

Latest updates to the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page
- CheckyesterdayChange DetectedThe record history now includes a new revision entry, Revision: v3.3.3, while the HHS Vulnerability Disclosure and the prior Revision: v3.3.2 entry were removed.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page shows a new revision tag, v3.3.2, replacing the previous v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check31 days agoChange DetectedThe page history shows a new revision v3.3.1 added and v3.2.0 removed; changes are limited to page version metadata and do not affect study data or trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedRemoved the banner notice about lapse in government funding and NIH operating status on the page. This change does not affect study data or page functionality.SummaryDifference0.6%

- Check52 days agoChange DetectedThe latest version adds updates to the study status and recruitment status in the record history, reflecting changes in the trial's progression. There are no evident additions of new documents or locations in the latest update.SummaryDifference0.1%

- Check81 days agoChange DetectedMajor change: updated operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference11%

Stay in the know with updates to Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.